UBS Maintains Buy on Teradyne, Lowers Price Target to $430
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and lowers the price target from $485 to $430.
UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and lowers the price target from $485 to $430.